The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
rac-6-(1-Aminooctan-2-yl)-3-(pyridin-3-yl)-5,6-dihydrothieno[2,3-c]pyridin-7(4H)-one ID: ALA5278471
Max Phase: Preclinical
Molecular Formula: C20H27N3OS
Molecular Weight: 357.52
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCC(CN)N1CCc2c(-c3cccnc3)csc2C1=O
Standard InChI: InChI=1S/C20H27N3OS/c1-2-3-4-5-8-16(12-21)23-11-9-17-18(14-25-19(17)20(23)24)15-7-6-10-22-13-15/h6-7,10,13-14,16H,2-5,8-9,11-12,21H2,1H3
Standard InChI Key: GVCQWUUSWMGXSK-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
0.7870 -0.0851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7870 -0.9101 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4990 -1.3184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2155 -0.9065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2110 -0.0851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4990 0.3315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9908 0.1729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4773 -0.4890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9981 -1.1561 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.2043 0.9697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6211 1.5533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8348 2.3475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6318 2.5611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2134 1.9818 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0046 1.1842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4994 -2.1434 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0731 -1.3236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6418 -0.9122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0731 -2.1486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6412 -2.5611 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.3557 -1.3257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0707 -0.9142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7845 -1.3277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4995 -0.9163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2134 -1.3298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
5 4 2 0
5 6 1 0
1 6 1 0
5 7 1 0
7 8 2 0
8 9 1 0
4 9 1 0
10 7 1 0
11 10 2 0
12 11 1 0
13 12 2 0
14 13 1 0
15 14 2 0
10 15 1 0
3 16 2 0
2 17 1 0
17 18 1 0
17 19 1 0
19 20 1 0
21 18 1 0
22 21 1 0
22 23 1 0
23 24 1 0
24 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 357.52Molecular Weight (Monoisotopic): 357.1875AlogP: 4.11#Rotatable Bonds: 8Polar Surface Area: 59.22Molecular Species: BASEHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.18CX LogP: 3.57CX LogD: 1.81Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.72Np Likeness Score: -0.50
References 1. Tanaka Y, Kurasawa O, Yokota A, Klein MG, Saito B, Matsumoto S, Okaniwa M, Ambrus-Aikelin G, Uchiyama N, Morishita D, Kimura H, Imamura S.. (2020) New Series of Potent Allosteric Inhibitors of Deoxyhypusine Synthase., 11 (8.0): [PMID:34345355 ] [10.1021/acsmedchemlett.0c00331 ]